Neuraxial anesthesia for labor and cesarean delivery in a parturient with hereditary antithrombin deficiency on recombinant human antithrombin infusion therapy

Abstract A recombinant human antithrombin (rhAT; generic name: antithrombin Alfa) has recently been developed. A 37 year-old parturient with hereditary antithrombin deficiency, receiving rhAT infusion therapy, who successfully received an epidural catheter for analgesia and anesthesia during labor a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical anesthesia 2010-09, Vol.22 (6), p.450-453
Hauptverfasser:	Pamnani, Anup, MD, Rosenstein, Megan, Darwich, Alaeldin, MD, Wolfson, Alexander, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Analgesia, obstetric, labor Anesthesia Anesthesia & Perioperative Care Anesthesia, Epidural - methods Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Anticoagulants Antithrombin Alfa Antithrombin deficiency Antithrombin III Deficiency - complications Antithrombin III Deficiency - drug therapy Antithrombins - administration & dosage Biological and medical sciences Cesarean delivery Cesarean Section - methods Childbirth & labor Drug therapy Epidural catheter Female Humans Infusions, Intravenous Medical sciences Molecular weight Pain Pain Medicine Parenteral nutrition Plasma Pregnancy Pregnancy Complications, Hematologic - drug therapy Recombinant human antithrombin Recombinant Proteins Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract A recombinant human antithrombin (rhAT; generic name: antithrombin Alfa) has recently been developed. A 37 year-old parturient with hereditary antithrombin deficiency, receiving rhAT infusion therapy, who successfully received an epidural catheter for analgesia and anesthesia during labor and cesarean delivery, is presented.
ISSN:	0952-8180 1873-4529
DOI:	10.1016/j.jclinane.2009.05.008